Oral Steroid Taper After Total Knee Arthroplasty

Summary

This study aims to evaluate the effectiveness of an oral methylprednisolone taper in reducing postoperative pain, opioid consumption, and nausea following primary total knee arthroplasty (TKA).

Eligibility

Inclusion Criteria:

* Any patient undergoing primary TKA with a diagnosis of osteoarthritis
* \> 18 years old
* Willingness to undergo randomization
* Patients who will be home by postoperative day (POD) #1 to start the dosing schedule that day (includes both ambulatory and POD #1 discharge patients)

Exclusion Criteria:

* Reported chronic corticosteroid or opiate use prior to surgery
* Prior Open Surgery on the Ipsilateral Knee
* Primary diagnosis other than osteoarthritis, including avascular necrosis, fracture, septic arthritis, or postoperative traumatic arthritis
* American Society of Anesthesiologists (ASA) score ≥ 4
* Reported history of liver disease, renal disease, or diabetes mellitus
* Current systemic fungal infection or other local infection
* Immunocompromised or immunosuppressed
* Current peptic ulcer disease
* History of psychosis, heart failure, myasthenia gravis, ocular herpes simplex virus, or systemic sclerosis
* Women with reported current pregnancy
* Known hypersensitivity to methylprednisolone
* ≤ 18 years old
* Inability to take oral medications
* Unable to provide consent

Conditions2

Locations1 site

Browse More Trials